5-HT(2C) receptor agonists: Pharmacological characteristics and therapeutic potential

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 913-924

  Martin, J R ^a,c   Bos M ^a   Jenck, F ^a   Moreau, J L ^a   Mutel, V ^a   Sleight, A J ^a   Wichmann, J ^a   Andrews, J S ^b   Berendsen, H H G ^b   Broekkamp, C L E ^b   Ruigt, G S F ^b   Kohler C ^a   Van Delft, A M L ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b NV ORGANON   (Netherlands)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 2 (4,4,7 TRIMETHYL 1,4 DIHYDRO INDENO[1,2 B]PYRROL 1 YL) 1 METHYLETHYLAMINE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 2 (CHLORO 5 FLUOR INDOL 1 YL) 1 METHYLETHYLAMINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BROLAMFETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUOXETINE; N (1 METHYL 5' INDOLYL)(3 PYRIDYL)UREA; N (2 NAPHTHYL) N' (3 PYRIDYL)UREA; ORG 35030; ORG 35035; RO 60 0332; RO 60 0491 001; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; DRUG DERIVATIVE; NAPHTHALENE DERIVATIVE; RO 60 0491; RO 60-0491; SEROTONIN AGONIST; SEROTONIN RECEPTOR; UREA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPULSION; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG POTENCY; DRUG RECEPTOR BINDING; FEEDING BEHAVIOR; FEMALE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; RECEPTOR AFFINITY; SEROTONINERGIC SYSTEM; SQUIRREL MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; AVOIDANCE BEHAVIOR; CEBIDAE; DBA MOUSE; DRUG EFFECT; METABOLISM; MOTOR ACTIVITY; OLFACTORY BULB; PHYSIOLOGY; SLEEP; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; FEEDING BEHAVIOR; FEMALE; MALE; MICE; MICE, INBRED DBA; MOTOR ACTIVITY; NAPHTHALENES; OLFACTORY BULB; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SAIMIRI; SEROTONIN AGONISTS; SLEEP; UREA;

EID: 0032219620     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Abramowski D, Rigo M, Duc D, Hoyer D and Staufenbiet M (1995) Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34:1635-1645.
2. Ahlenius SN, Fernandez-Guasti A, Hjorth S and Larsson K (1986) Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. Eur J Pharmacol 124:361-363.
3. 2B receptor function? Br J Pharmacol 117:suppl 178P.
4. Andrews JS, Jansen JHM, Linders S, Princen A, Drinkenburg WHIM, Coenders CJH and Vossen JHM (1994) Effects of imipramine and mirtazepine on operant performance in the rat. Drug Dev Res 32:58-66.
5. 2 receptor subtypes: A family re-united? TIPS 16:105-110.
6. Berendsen HHG and Broekkamp CLE (1994) Comparison of stimulus properties of fluoxetine and 5HT receptor agonists in a conditioned taste aversion procedure. Eur J Pharmacol 253:83-89.
7. Berendsen HHG (1995) Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol Ther 66:17-37.
8. Berendsen HHG and Gower AJ (1986) Opiate-androgen interactions in drug-induced yawning and penile erections in the rat. Neuroendocrinology 42:185-190.
9. 1C receptors in drug-induced penile erections in rats. Psychopharmacology 101:57-61.
10. Bourson A, Wanner D, Wyler R, Petit N, Zwingelstein C, Rudler A and Sleight AJ (1996) Pharmacological evaluation of the discriminative stimulus of metachlorophenylpiperazine. Pharmacol Biochem Behav 53:107-114.
11. 1C-receptors for anti-depressant effects. Pol J Pharmacol Pharm 44:suppl 20.
12. Broekkamp CLE, Garrigou D and Lloyd KG (1980) Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacol Biochem Behav 13:643-646.
13. Den Boer JA and Westenberg HGM (1995) Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review. Human Psychopharmacol 10:3173-5183.
14. 2B receptor protein in the rat brain. Br J Pharmacol 115:105P.
15. Goa KL and Ward A (1986) Buspirone: A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114-129.
16. Jenck F, Moreau J-L, Berendsen HG, Bos M, Broekkamp CLE, Martin JR, Wichmann J and Van Delft AML (1998) Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats. Eur Neuropsychopharmacol, in press.
17. 1C receptors and antidepressants. Prog Neuro-Psychopharmacol Biol Psychiat 18:563-574.
18. Kahn RS and Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139-1166.
19. Kennedy SH and Goldbloom DS (1994) Advances in the treatment of anorexia nervosa and bulimia nervosa. CNS Drugs 1:201-212.
20. Kennett GA (1993) 5-HT1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 2:317-362.
21. 2B receptor agonist, BW 723C86, on three rat models of anxiety. Br J Pharmacol 117:1443-1448.
22. 2C/2B receptor antagonist. Br J Pharmacol 111:797-802.
23. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R and Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiat 138:429-434.
24. Leander JD (1987) Fluoxetine suppressed palatability-induced ingestion. Psychopharmacology 91:285-287.
25. Loi V, Lai M, Pisano MR and Del Zompo M (1995) Panicogenic effect of sumatriptan: A pilot study. Pharmacol Res 31:suppl 348.
26. 2-like receptor. Expression in brain, heart and intestine. FEBS Letters 312:203-207.
27. Lucki K, Kreider MS and Simansky KJ (1988) Reduction of feeding behavior by the serotonin uptake inhibitor sertraline. Psychopharmacology 96:289-295.
28. 1A receptor mediated inhibition of lordosis behavior. Neuropharmacology 35:497-501.
29. McPherson GA (1985) KINETIC, EBCA, LIGAND, LOWRY: A collection of radioligand binding analysis programmes. Biosoft, Cambridge, MA.
30. Milne RJ and Heel RC (1991) Ondansetron: Therapeutic use as an antiemetic. Drugs 41:574-595.
31. Moreau J-L, Bos M, Jenck F, Martin JR, Mortas P and Wichmann J (1996) 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6:169-175.
32. 1A receptor antagonist (S)-UH-301 in rodents and monkeys. Brain Res Bull 29:901-904.
33. 2C receptor activation in rats. Psychopharmacology 110:140-144.
34. 1A selective ligand and its effects in animal models of anxiety: Comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol 99:343-349.
35. Munson PJ and Rodbard D (1980) LIGAND: A versatile computerized approach for characterisation of ligand-binding systems. Anal Biochem 107:220-239.
36. O'Donnell JM and Seiden LS (1983) Differential-reinforcement-of-low-rate 72-sec schedule: Selective effects of antidepressant drugs. J Pharmacol Exp Ther 224: 80-88.
37. 2C receptors. Mol Brain Res 23:163-178.
38. Rasmussen SA, Eisen JL and Pato MT (1993) Current issues in the pharmacologic management of obsessive compulsive disorder. J Clin Psychiat 54:Suppl. 4-9.
39. Ruigt GSF, Engelen S, Gerrits A and Verbon F (1993) Computer-based prediction of psychotropic drug classes based on a discriminant analysis of drug effects on rat sleep. Neuropsychobiology 28:138-153.
40. Ruigt GSF, Van Proosdij JN and Van Delft AML (1989a) A large scale, high resolution, automated system for rat sleep staging. I. Methodology and technical aspects. Electroencephalogr Clin Neurophysiol 73:52-63.
41. Ruigt GSF, Van Proosdij JN and Van Wezenbeek LACM (1989b) A large scale, high resolution, automated system for rat sleep staging. II. Validation and application. Electroencephalogr Clin Neurophysiol 73:64-71.
42. Saxena PR (1995) Serotonin receptors: Subtypes, functional responses and therapeutic relevance. Pharmacol Ther 66:339-368.
43. 2B receptors: An early step in the generation of migraine headache. Eur J Neurosci 8:959-967.
44. 2A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities. Biochem Pharmacol 51:71-76.
45. 2C serotonin receptors. Nature (Lond) 374:542-546.
46. Wood A, Smith C, Szewczak M, Dunn RW, Cornfeldt M and Corbett R (1993) Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: A potential model for obsessive compulsive disorder. Psychopharmacology 112:195-198.
47. Zohar J and Cohen R (1995) Serotonin function in OCD: Implications for treatment. Abstract book of the Second International Conference on New Directions in Affective Disorders, Jerusalem, September 3-8 (Abstract No. S 253).